Lupin share analysis
Lupin passes 4 of 5 fundamental tests, a score of 8/10. On the daily chart it is in an downtrend, RSI 35, 22% below its 52-week high: downtrend: no long setup. Its own volatility puts the likely range at ₹1,854–₹2,075 a month from now and ₹1,615–₹2,383 in a year (68% bands).
Fundamentals 8/10
- Market cap
- ₹89,702 Cr
- P/E · forward
- 16.2 · 19.3
- PEG · P/B
- — · 4.0
- ROE · net margin
- — · +18%
- Revenue · earnings growth
- +32% · +16%
- Debt / equity
- 29%
- Dividend · beta
- 0.9% · 0.2
- Next results
- 5 Nov 2026
- ✓ Net margin above 10%
- ✓ Revenue growing over 10%
- ✓ Earnings growing
- ✓ Debt/equity under 100%
- ✕ Forward P/E under trailing (earnings expected up)
Swing technicals (daily)
- Trend
- down · 50d below 200d
- RSI(14)
- 35
- 20 / 50 / 200-day avg
- ₹2,027 / ₹2,121 / ₹2,251
- 20-day breakout
- above ₹2,135 · below ₹1,926
- ATR(14)
- ₹39.24 (2.0% a day)
- 52-week range
- ₹1,900 – ₹2,530
- Return 3m · 6m · 1y
- -20% · -16% · -1%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | ₹1,854 – ₹2,075 (-5% / +6%) |
| 3 mo | ₹1,780 – ₹2,162 (-9% / +10%) |
| 6 mo | ₹1,709 – ₹2,251 (-13% / +15%) |
| 1 year | ₹1,615 – ₹2,383 (-18% / +21%) |
Analysts (36): hold, mean target ₹2,446 (+25%)
From its own volatility (19% a year), no drift assumed: what its swings allow, not a forecast.
Lupin news · last two days
News lean: Neutral- 12h agoWhat to Watch on TV This Week: Nobody Wants This, Lupin, WNBA Finals, and Moretelltaletv
- 15h agoWhat to Stream: ‘Moana,’ ‘Modern Warfare 4,’ Dolly Parton tribute, ‘Lupin’ and John LegendHartford Courant
- 25h agoLupin Q1 resultsThe Economic Times
- 36h agoThe Appeal of the Drama 'Political Lupin' and Why We Should Watch It Nownote
- 2d agoBuy, sell or hold: L&T, Mahindra & Mahindra, ICICI Bank, Lupin, Siemens Energy and LTM — Ask ProfitNDTV Profit on MSN
- 3d agoSheet music for Yuji Ohno's "Lupin the Third Theme '78" is now on sale!note
- 3d agoLupin ESG rating falls to 70 in FY26 on lower social, governance scoresscanx
- 5d agoVet-Founded Omni Builds Joint, Skin and Calming Support Into Lupin-Based Dog Foodvegconomist
- 5d agoLupin Launches Triple-Combination Formoflo-G MDI for COPD Treatment in IndiaMachine Maker
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.